EIF2A and Alzheimer disease: In a recent study, ISRIB, a newly developed small molecule that binds to and stabilizes eIF2B, reversed the effect of phosphorylated eIF2α, restored hippocampal protein synthesis, and rescued impaired long-term memory and synaptic function in the mouse model of AD [150].